Based on these results, we concluded that VEGFR-TKIs dramatically enhance the occurrence of hypertension in patients of cancer and that intensive monitoring for VEGFR-TKI-associated hypertensive events is suggested throughout the management of hypertension. Here, KDR is linked to Hypertension.